Revolut CEO Nik Storonsky announced the digital bank plans to go public by 2028, delaying earlier expectations. The London-based fintech aims to list its shares in two years, making it one of Europe's most anticipated IPOs. The move reflects the company's strategic timing, with no specific valuation or funding details disclosed.
Jersey Mike's, a sandwich chain, has confidentially filed for an IPO, following Blackstone's acquisition of a majority stake in 2024. The deal valued the company at approximately $8 billion. The IPO aims to expand the company's growth and market presence, with no specific timeline announced. This move reflects ongoing private equity interest in the fast-food sector.
Data center developers are returning to the junk-debt market to fund AI infrastructure projects, leading to a wave of new bond issuance. This trend reflects growing investment in artificial intelligence and cloud computing, despite concerns over high borrowing costs and market volatility. The move signals confidence in AI's long-term growth prospects.
Hungary’s incoming Prime Minister Peter Magyar announced his new cabinet on April 20, 2026, aiming to revitalize the country’s economy and repair European relations. The cabinet includes key ministers tasked with leading Hungary’s economic reset amid ongoing challenges. This move signals Hungary’s focus on economic recovery and strengthening ties within the European Union.
Eli Lilly has agreed to acquire cancer drug maker Kelonia in a deal valued at up to $7 billion. Kelonia is developing in vivo CAR-T technology, which reprograms patients' T-cells inside the body to target cancer. The acquisition aims to enhance Eli Lilly’s oncology portfolio and is part of its broader strategy to expand its presence in innovative cancer treatments.
Iran is hesitating on peace talks, while the UAE is exploring a US financial lifeline amid ongoing geopolitical tensions. The developments, reported on April 20, 2026, highlight regional economic and political uncertainties. These moves could impact global markets, as key policymakers and analysts discuss potential implications for macro-finance stability and international relations.
Psychedelic stocks surged in premarket trading on April 20, 2026, after President Donald Trump signed an executive order to expedite research and access to psychedelic therapies. The move aims to accelerate development in the sector, boosting investor confidence and driving up shares of companies involved in psychedelic-related treatments. The order marks a significant policy shift in the industry.
